Purdue Pharma files new bankruptcy plan Bankrupt drugmaker Purdue Pharma has filed a new bankruptcy plan, a major step towards finalising a proposed opioid settlement of at least $7.4 billion after a setback in the US Supreme Court last year. Business • 19 Mar
Purdue Pharma files new bankruptcy plan Bankrupt drugmaker Purdue Pharma has filed a new bankruptcy plan, a major step towards finalising a proposed opioid settlement of at least $7.4 billion after a setback in the US Supreme Court last year. Business • 19 Mar
Bitter Pill: US opioid crisis remains despite settlement Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's opioid epidemic, writes Adam Maguire. Business • 18 Feb
Bitter Pill: US opioid crisis remains despite settlement Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's opioid epidemic, writes Adam Maguire. Business • 18 Feb
Purdue deal to rank among biggest in pharma history OxyContin maker Purdue Pharma LP has reached a tentative multibillion-dollar agreement with some plaintiffs aimed at settling thousands of lawsuits over its alleged role in the US opioid crisis. Business • 16 Sep 19
Purdue deal to rank among biggest in pharma history OxyContin maker Purdue Pharma LP has reached a tentative multibillion-dollar agreement with some plaintiffs aimed at settling thousands of lawsuits over its alleged role in the US opioid crisis. Business • 16 Sep 19
Purdue files for bankruptcy to settle opioid crisis Purdue Pharma is to file for bankruptcy in a settlement agreement that it hopes will provide more than $10 billion to address the opioid crisis, the company said in a statement today. Business • 16 Sep 19
Purdue files for bankruptcy to settle opioid crisis Purdue Pharma is to file for bankruptcy in a settlement agreement that it hopes will provide more than $10 billion to address the opioid crisis, the company said in a statement today. Business • 16 Sep 19
Purdue in talks to settle opioid lawsuits OxyContin maker Purdue Pharma and its owners, the Sackler family, are in discussions to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion. Business • 28 Aug 19
Purdue in talks to settle opioid lawsuits OxyContin maker Purdue Pharma and its owners, the Sackler family, are in discussions to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion. Business • 28 Aug 19
